Literature DB >> 26995457

Factors associated with operative treatment of enthesopathy of the extensor carpi radialis brevis origin.

Amir Reza Kachooei1, Mojtaba Talaei-Khoei2, Aram Faghfouri2, David Ring3.   

Abstract

BACKGROUND: This study investigated the factors associated with variation in the rate of surgery for enthesopathy of the extensor carpi radialis brevis (eECRB).
METHODS: We used a large database from 3 academic hospitals including 5964 patients with the diagnosis of eECRB from 2001 to 2007. Of those, 244 patients (4%) had surgery for eECRB. We used the date of the first encounter as the date of diagnosis. We also recorded the date of the first cortisone injection and surgery for eECRB. We used Cox multivariable regression analysis to find factors associated with surgery. We considered the following explanatory factors: age, sex, race, diabetes, a diagnosis of major depression, a diagnosis of an anxiety disorder, hospital, provider (surgeon vs. nonsurgeon), corticosteroid injection, and the time from diagnosis to the first cortisone injection.
RESULTS: The hazard ratio of having surgery was 12-times greater if the initial provider was an orthopedic surgeon rather a nonsurgeon and 1.7-times greater at 1 of the 2 hospitals. The rate of surgery varied substantially, ranging from 0% to 22%. Corticosteroid injection delayed the time to surgery but was ultimately associated with a higher rate of surgery. The majority (86%) of surgeries were done within 1 year of the first documented office visit.
CONCLUSIONS: It seems likely that an emphasis on the preferences and values of the patient rather than the surgeon would decrease the variation in surgery rates for eECRB observed in this study. Methods for optimizing the influence of patient preferences and values on decision making (eg, decision aids) merit additional study.
Copyright © 2016 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Extensor carpi radialis brevis; corticosteroid injections; enthesopathy; lateral epicondylitis; tennis elbow; variation

Mesh:

Year:  2016        PMID: 26995457     DOI: 10.1016/j.jse.2015.12.019

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  7 in total

1.  Surgical Treatment of Tennis Elbow; Minimal Incision Technique.

Authors:  Morteza Nakhaei Amroodi; Ali Mahmuudi; Mostafa Salariyeh; Arash Amiri
Journal:  Arch Bone Jt Surg       Date:  2016-10

2.  Perceived Pain Severity and Disability After the Recurrence of Tennis Elbow Following a Local Corticosteroid Injection.

Authors:  Ehsan Asghari; Ahmadreza Zarifian; Mohammad Javad Shariyate; Amir R Kachooei
Journal:  Arch Bone Jt Surg       Date:  2022-09

3.  CORR Insights®: Which Psychological Variables Are Associated With Pain and Function Before Surgery for de Quervain's Tenosynovitis? A Cross-sectional Study.

Authors:  David Ring
Journal:  Clin Orthop Relat Res       Date:  2019-12       Impact factor: 4.176

4.  Arthroscopic Recession Technique in the Surgery of Tennis Elbow by Sharp Cutting the Extensor Carpi Radialis Brevis (ECRB) Tendon Origin.

Authors:  Mohamad Behazin; Amir R Kachooei
Journal:  Arch Bone Jt Surg       Date:  2021-03

5.  Epidemiology and Disease Burden of Lateral Epicondylitis in the USA: Analysis of 85,318 Patients.

Authors:  Ryan M Degen; Matthew S Conti; Christopher L Camp; David W Altchek; Joshua S Dines; Brian C Werner
Journal:  HSS J       Date:  2017-06-05

6.  Effect of Metabolic Syndrome on the Functional Outcome of Corticosteroid Injection for Lateral Epicondylitis: Retrospective Matched Case-Control Study.

Authors:  Young Hak Roh; Minjoon Oh; Jung Ho Noh; Hyun Sik Gong; Goo Hyun Baek
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

7.  Treatment after traumatic shoulder dislocation: a systematic review with a network meta-analysis.

Authors:  Lauri Kavaja; Tuomas Lähdeoja; Antti Malmivaara; Mika Paavola
Journal:  Br J Sports Med       Date:  2018-06-23       Impact factor: 13.800

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.